{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:47:02Z","timestamp":1794988022774,"version":"4.9.1"},"reference-count":304,"publisher":"Elsevier","isbn-type":[{"value":"9780128233573","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/b978-0-12-823357-3.00008-2","type":"book-chapter","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:47:29Z","timestamp":1706824049000},"page":"17-42","source":"Crossref","is-referenced-by-count":12,"title":["The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/01.WNL.0000115105.05966.A7","article-title":"Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial","volume":"62","author":"Ahonen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/01.wnl.0000238179.79888.44","article-title":"A randomized trial of rizatriptan in migraine attacks in children","volume":"67","author":"Ahonen","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1468-2982.1999.019005525.x","article-title":"Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group","volume":"19","author":"Ahrens","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0196-0644(95)70259-8","article-title":"Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study","volume":"25","author":"Akpunonu","year":"1995","journal-title":"Ann Emerg Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/head.13737","article-title":"A phase 1, randomized, open-label, safety, tolerability, and comparative bioavailability study of intranasal dihydroergotamine powder (STS101), intramuscular dihydroergotamine mesylate, and intranasal DHE mesylate spray in healthy adult subjects","volume":"60","author":"Albrecht","year":"2020","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0333102410378048","article-title":"Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Allais","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0333102413500726","article-title":"Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study","volume":"34","author":"Almas","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrneurol.2015.29","article-title":"Pharmacological treatment of migraine during pregnancy and breastfeeding","volume":"11","author":"Amundsen","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/head.12259","article-title":"Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial","volume":"54","author":"Asadollahi","year":"2014","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/pds.890","article-title":"Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials","volume":"13","author":"Ashcroft","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1468-2982.1992.1201039.x","article-title":"Sumatriptan in the treatment of acute migraine with aura","volume":"12","author":"Banerjee","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0065","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1185\/030079904X15200","article-title":"Effects of a fast disintegrating\/rapid release oral formulation of sumatriptan on functional ability in patients with migraine","volume":"20","author":"Barbanti","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10194-012-0440-y","article-title":"Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial","volume":"13","author":"Barbanti","year":"2012","journal-title":"J Headache Pain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0075","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1526-4610.2010.01662.x","article-title":"Revisiting the role of ergots in the treatment of migraine and headache","volume":"50","author":"Baron","year":"2010","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0080","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.44.9.1587","article-title":"Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group","volume":"44","author":"Bates","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1526-4610.1988.hed2804263.x","article-title":"Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine","volume":"28","author":"Baumel","year":"1988","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1526-4610.1996.3603144.x","article-title":"Effectiveness of subcutaneous dihydroergotamine by home injection for migraine","volume":"36","author":"Becker","year":"1996","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0095","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/head.12904","article-title":"Is the generally held view that intravenous dihydroergotamine is effective in migraine based on wrong \u201cgeneral consensus\u201d of one trial? a critical review of the trial and subsequent quotations","volume":"56","author":"Bekan","year":"2016","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1212\/WNL.39.4.590","article-title":"Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache","volume":"39","author":"Belgrade","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0196-0644(05)81507-0","article-title":"A comparative trial of three agents in the treatment of acute migraine headache","volume":"19","author":"Bell","year":"1990","journal-title":"Ann Emerg Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0110","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1742-1241.1999.tb11812.x","article-title":"A dose-defining study of sumatriptan suppositories in the acute treatment of migraine","volume":"53","author":"Bertin","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11916-003-0011-7","article-title":"Ergotamine and dihydroergotamine: a review","volume":"7","author":"Bigal","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1526-4610.2008.01092.x","article-title":"A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008616.pub2","article-title":"Zolmitriptan for acute migraine attacks in adults","author":"Bird","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000008094","article-title":"Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine","volume":"42","author":"Bomhof","year":"1999","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1742-1241.2000.tb11905.x","article-title":"A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine","volume":"54","author":"Boureau","year":"2000","journal-title":"Int J Clin Pract"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/03331024850050S3221","article-title":"Efficacy of dihydroergotamine nasal spray in the acute treatment of migraine attacks","volume":"5","author":"Bousser","year":"1985","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2796.1993.tb00732.x","article-title":"Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group","volume":"234","author":"Bousser","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1468-2982.2005.00981.x","article-title":"Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing","volume":"25","author":"Brandes","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0155","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","article-title":"Sumatriptan-naproxen for acute treatment of migraine: a randomized trial","volume":"297","author":"Brandes","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0160","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1468-2982.2009.01840.x","article-title":"Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks","volume":"29","author":"Brandes","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1526-4610.2001.01159.x","article-title":"Efficacy and tolerability of subcutaneous sumatriptan for acute migraine: a comparison between ethnic groups","volume":"41","author":"Burke-Ramirez","year":"2001","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0170","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s100720070064","article-title":"Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks","volume":"21","author":"Bussone","year":"2000","journal-title":"Neurol Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0175","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.1991.03460210077033","article-title":"Treatment of acute migraine with subcutaneous sumatriptan","volume":"265","author":"Cady","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0180","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.43.7.1363","article-title":"Efficacy of subcutaneous sumatriptan in repeated episodes of migraine","volume":"43","author":"Cady","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0185","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1526-4610.2000.00144.x","article-title":"Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study","volume":"40","author":"Cady","year":"2000","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0190","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1185\/030079904X2745","article-title":"Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe","volume":"20","author":"Cady","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0195","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1526-4610.2006.00466.x","article-title":"Efficacy of Rizatriptan 10 mg administered early in a migraine attack","volume":"46","author":"Cady","year":"2006","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1526-4610.2009.01412.x","article-title":"Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response","volume":"49","author":"Cady","year":"2009","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/head.12472","article-title":"A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)","volume":"55","author":"Cady","year":"2015","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3810\/pgm.2014.03.2743","article-title":"Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85\/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?","volume":"126","author":"Calhoun","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1526-4610.1986.hed2604168.x","article-title":"A controlled study of dihydroergotamine in the treatment of acute migraine headache","volume":"26","author":"Callaham","year":"1986","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/head.12601","article-title":"Triptans in the acute treatment of migraine: a systematic review and network meta-analysis","volume":"55","author":"Cameron","year":"2015","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0149-2918(04)90020-3","article-title":"Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study","volume":"26","author":"Carpay","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0230","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1526-4610.2010.01622.x","article-title":"Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine","volume":"50","author":"Charles","year":"2010","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00023210-200317090-00005","article-title":"Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet","volume":"17","author":"Charlesworth","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0240","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1526-4610.2007.00884.x","article-title":"Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine","volume":"47","author":"Chen","year":"2007","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000067018","article-title":"Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine\/caffeine in migraine","volume":"49","author":"Christie","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0250","first-page":"3559","article-title":"Pain control in migraine attacks: results from a double-blind, randomized, within-patient, placebo-controlled trial comparing diclofenac-K and ergotamine\u2013caffeine","volume":"16","author":"Cortelli","year":"1996","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.1.5377.221","article-title":"Clinical trial of inhaled ergotamine tartrate in migraine","volume":"1","author":"Crooks","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0260","first-page":"S5","article-title":"Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths","volume":"45","author":"Cutler","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0265","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1526-4610.2012.02124.x","article-title":"Dihydroergotamine, ergotamine, methysergide and sumatriptan\u2014basic science in relation to migraine treatment","volume":"52","author":"Dahlof","year":"2012","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0270","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1468-2982.1992.1204214.x","article-title":"Sumatriptan injection is superior to placebo in the acute treatment of migraine\u2014with regard to both efficacy and general well-being","volume":"12","author":"Dahl\u00f6f","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1468-1331.1998.550469.x","article-title":"Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study","volume":"5","author":"Dahlof","year":"1998","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0280","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/WNL.57.10.1811","article-title":"Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine","volume":"57","author":"Dahl\u00f6f","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0285","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.bjp.0701770","article-title":"Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B\/1D and novel receptors","volume":"123","author":"De Vries","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0290","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1526-4610.2011.02039.x","article-title":"Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study","volume":"52","author":"Derosier","year":"2012","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0295","doi-asserted-by":"crossref","first-page":"e1411","DOI":"10.1542\/peds.2011-2455","article-title":"Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine","volume":"129","author":"Derosier","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0300","article-title":"Sumatriptan (intranasal route of administration) for acute migraine attacks in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0305","article-title":"Sumatriptan (oral route of administration) for acute migraine attacks in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0310","article-title":"Sumatriptan (rectal route of administration) for acute migraine attacks in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0315","article-title":"Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0320","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1526-4610.2003.03161.x","article-title":"Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial","volume":"43","author":"Di Monda","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archfami.7.3.234","article-title":"Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine","volume":"7","author":"Diamond","year":"1998","journal-title":"Arch Fam Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0330","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00207454.2011.605191","article-title":"The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the \u201cAct when mild\u201d study","volume":"121","author":"D\u00edaz-Insa","year":"2011","journal-title":"Int J Neurosci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0335","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1468-2982.1999.019006581.x","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0340","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.0333-1024.2001.00222.x","article-title":"The efficacy and safety of sc alniditan vs. sc sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial","volume":"21","author":"Diener","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0345","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047960","article-title":"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison","volume":"47","author":"Diener","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0350","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000079544","article-title":"Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms","volume":"52","author":"Diener","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0355","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1526-4610.2005.05151.x","article-title":"Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial","volume":"45","author":"Diener","year":"2005","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1526-4610.1995.hed3504177.x","article-title":"Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine","volume":"35","author":"Dihydroergotamine Nasal Spray Multicenter Investigators","year":"1995","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0365","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/0333102409359314","article-title":"Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study","volume":"30","author":"Djupesland","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0370","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1526-4610.2004.04078.x","article-title":"Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine","volume":"44","author":"Dodick","year":"2004","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/00023210-200519020-00003","article-title":"Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study","volume":"19","author":"Dodick","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.2002.00319.x","article-title":"Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine","volume":"22","author":"Dowson","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0385","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1468-2982.2002.00394.x","article-title":"Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"22","author":"Dowson","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0390","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1526-4610.2001.01191.x","article-title":"Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache","volume":"41","author":"Edwards","year":"2001","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0395","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/head.12052","article-title":"Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function","volume":"53","author":"Edwards","year":"2013","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0400","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1468-2982.2002.00372.x","article-title":"Efficacy and safety of eletriptan 20 mg, 40 mg and 80 mg in Japanese migraineurs","volume":"22","author":"Eletriptan Steering Committee in Japan","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0405","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/BF01642910","article-title":"Subcutaneous sumatriptan in the acute treatment of migraine. Sumatriptan International Study Group","volume":"238","author":"Ensink","year":"1991","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0410","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/head.12375","article-title":"Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry","volume":"54","author":"Ephross","year":"2014","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0415","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/01.wnl.0000231138.18629.d5","article-title":"Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen","volume":"67","author":"Evers","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0420","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0029-7844(95)00288-3","article-title":"The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group","volume":"86","author":"Facchinetti","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0425","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1468-2982.2003.00554.x","article-title":"Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan","volume":"23","author":"F\u00e4rkkil\u00e4","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0430","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0435","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0091270003252242","article-title":"Interaction between ketoconazole and almotriptan in healthy volunteers","volume":"43","author":"Fleishaker","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0440","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1526-4610.1997.3703129.x","article-title":"Continuous intravenous dihydroergotamine in the treatment of intractable headache","volume":"37","author":"Ford","year":"1997","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0445","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2007.01053.x","article-title":"Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment","volume":"48","author":"Freitag","year":"2008","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0450","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1526-4610.2007.00954.x","article-title":"Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study","volume":"48","author":"Freitag","year":"2008","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0455","first-page":"170","article-title":"Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo","volume":"11","author":"Friedman","year":"1989","journal-title":"Clin Ther"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0460","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/01.WNL.0000150904.28131.DD","article-title":"A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines","volume":"64","author":"Friedman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0465","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1526-4610.2006.00467.x","article-title":"A clinical trial of trimethobenzamide\/diphenhydramine versus sumatriptan for acute migraines","volume":"46","author":"Friedman","year":"2006","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0470","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0333102413510213","article-title":"Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study","volume":"34","author":"Fujita","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0475","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archneur.1996.00550120097022","article-title":"Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group","volume":"53","author":"Gallagher","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0480","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1468-2982.2003.00593.x","article-title":"Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine","volume":"23","author":"Garcia-Ramos","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0485","first-page":"551","article-title":"Treatment of migraine","volume":"206","author":"General Practitioner Research Group","year":"1971","journal-title":"Practitioner"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0490","first-page":"633","article-title":"Intravenous valproate versus subcutaneous sumatriptan in acute migraine attack","volume":"53","author":"Ghaderibarmi","year":"2015","journal-title":"Acta Med Iran"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0495","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1468-2982.1997.1706647.x","article-title":"Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine","volume":"17","author":"Gijsman","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0500","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0140-6736(91)90666-D","article-title":"Oral sumatriptan in acute migraine","volume":"338","author":"Goadsby","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0505","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/WNL.54.1.156","article-title":"Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan","volume":"54","author":"Goadsby","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0510","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-2982.2008.01546.x","article-title":"Early vs. non-early intervention in acute migraine-\u2018Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan","volume":"28","author":"Goadsby","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0515","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1526-4610.2002.02012.x","article-title":"Frovatriptan for the acute treatment of migraine: a dose-finding study","volume":"42","author":"Goldstein","year":"2002","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0520","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1526-4610.1998.3810737.x","article-title":"Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group","volume":"38","author":"Goldstein","year":"1998","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0525","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1526-4610.2012.02198.x","article-title":"A sumatriptan iontophoretic transdermal system for the acute treatment of migraine","volume":"52","author":"Goldstein","year":"2012","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0530","series-title":"Treatment of Migraine","author":"Graham","year":"1955"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0535","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1526-4610.1994.hed3410559_a.x","article-title":"Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group","volume":"34","author":"Gross","year":"1994","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0540","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.1978.hed1801035.x","article-title":"A comparative trail of ergotamine tartrate, acetyl salicylic acid and a dextropropoxyphene compound in acute migraine attacks","volume":"18","author":"Hakkarainen","year":"1978","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0545","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(79)90343-X","article-title":"Tolfenamic acid is as effective as ergotamine during migraine attacks","volume":"2","author":"Hakkarainen","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0550","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/j.1552-4604.1980.tb01674.x","article-title":"Mild analgesics as an alternative to ergotamine in migraine. A comparative trial with acetylsalicylic acid, ergotamine tartrate, and a dextropropoxyphene compound","volume":"20","author":"Hakkarainen","year":"1980","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0555","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/01.WNL.0000110312.36809.7F","article-title":"Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice","volume":"62","author":"Hall","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0560","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.48.4.1100","article-title":"Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults?","volume":"48","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0565","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1526-4610.2008.01335.x","article-title":"Ten years of rizatriptan: from development to clinical science and future directions","volume":"49","author":"Hargreaves","year":"2009","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0570","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0149-2918(00)80068-5","article-title":"Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group","volume":"22","author":"Havanka","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0580","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4610.1993.hed3308432.x","article-title":"Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble","volume":"33","author":"Henry","year":"1993","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0585","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0333102489009S10217","article-title":"A comparison of DHE nasal spray and cafergot in acute migraine","volume":"9","author":"Hirt","year":"1989","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0590","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","article-title":"Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial","volume":"372","author":"Ho","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0595","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0333102412451358","article-title":"Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design","volume":"32","author":"Ho","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0600","first-page":"241","article-title":"A new product in the treatemnt of migraine: a preliminary report","volume":"20","author":"Horton","year":"1945","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0605","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1129-2377-14-7","article-title":"Triptans in prevention of menstrual migraine: a systematic review with meta-analysis","volume":"14","author":"Hu","year":"2013","journal-title":"J Headache Pain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0610","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1526-4610.2007.00672.x","article-title":"The discovery of a new drug class for the acute treatment of migraine","volume":"47","author":"Humphrey","year":"2007","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0615","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1468-29821995.1505423.x","article-title":"Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice","volume":"15","author":"Jensen","year":"1995","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0620","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2165\/11537990-000000000-00000","article-title":"Triptans for the management of migraine","volume":"70","author":"Johnston","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0625","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2796.1992.tb00973.x","article-title":"Ketoprofen and ergotamine in acute migraine","volume":"231","author":"Kangasniemi","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0630","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2217\/pmt-2017-0036","article-title":"Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray","volume":"7","author":"Kellerman","year":"2017","journal-title":"Pain Manag"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0635","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1468-2982.1988.0803175.x","article-title":"Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks","volume":"8","author":"Kinnunen","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0640","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1468-2982.2000.00079.x","article-title":"Rizatriptan wafer\u2014sublingual vs. placebo at the onset of acute migraine","volume":"20","author":"Klapper","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0645","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0333102491011S1186","article-title":"The emergency treatment of acute migraine headache; a comparison of intravenous dihydroergotamine, dexamethasone, and placebo","volume":"11","author":"Klapper","year":"1991","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0650","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1526-4610.1991.hed3108523.x","article-title":"Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches","volume":"31","author":"Klapper","year":"1991","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0655","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1526-4610.1992.hed3201021.x","article-title":"Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches","volume":"32","author":"Klapper","year":"1992","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0660","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1526-4610.1993.hed3310560.x","article-title":"Current emergency treatment of severe migraine headaches","volume":"33","author":"Klapper","year":"1993","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0665","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1468-2982.2004.00735.x","article-title":"Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild","volume":"24","author":"Klapper","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0670","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1526-4610.1997.3710640.x","article-title":"Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group","volume":"37","author":"Klassen","year":"1997","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0675","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1468-2982.2004.00707.x","article-title":"Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets","volume":"24","author":"Kolodny","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2009.11.020","article-title":"A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department","volume":"56","author":"Kostic","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0685","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.51.3.773","article-title":"A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group","volume":"51","author":"Kramer","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0690","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/03331024850050S348","article-title":"Dihydroergotamine nasal spray in the treatment of migraine attacks","volume":"5","author":"Krause","year":"1985","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0695","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1590\/S0004-282X2000000300006","article-title":"Naproxen sodium decreases migraine recurrence when administered with sumatriptan","volume":"58","author":"Krymchantowski","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0700","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1468-2982.2006.01136.x","article-title":"Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study","volume":"26","author":"Krymchantowski","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0705","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-1331.2006.01594.x","article-title":"Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy","volume":"14","author":"Lainez","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0710","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1368-5031.2004.00295.x","article-title":"Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine","volume":"58","author":"Landy","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0715","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/head.12214","article-title":"Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan\/naproxen sodium combination","volume":"54","author":"Landy","year":"2014","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0720","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s10194-018-0881-z","article-title":"Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study","volume":"19","author":"Landy","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0725","article-title":"Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults","volume":"4","author":"Law","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000007996","article-title":"Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks","volume":"41","author":"Le Jeunne","year":"1999","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0735","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000441-193804000-00005","article-title":"Ergonovinve versus Ergotamine as a terminator of migraine headaches","volume":"195","author":"Lennox","year":"1938","journal-title":"Am J Med Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0740","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1542\/peds.2007-0085","article-title":"Efficacy of zolmitriptan nasal spray in adolescent migraine","volume":"120","author":"Lewis","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0745","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1526-4610.2008.01138.x","article-title":"Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial","volume":"48","author":"Linder","year":"2008","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0750","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1526-4610.2000.00143.x","article-title":"2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study","volume":"40","author":"Lipton","year":"2000","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0755","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1468-2982.2008.01806.x","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a placebo-controlled, crossover study","volume":"29","author":"Lipton","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0760","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/head.13309","article-title":"DFN-02 (sumatriptan 10 mg with a permeation enhancer) nasal spray vs placebo in the acute treatment of migraine: a double-blind, placebo-controlled study","volume":"58","author":"Lipton","year":"2018","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0765","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1526-4610.2004.04027.x","article-title":"Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study","volume":"44","author":"Loder","year":"2004","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0770","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1185\/030079905X28926","article-title":"Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo-controlled trial","volume":"21","author":"Loder","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0775","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1468-2982.2007.01313.x","article-title":"Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies","volume":"27","author":"Mannix","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0780","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1526-4610.2007.00855.x","article-title":"Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies","volume":"47","author":"Mannix","year":"2007","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0785","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0790","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.1988.0802083.x","article-title":"Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache","volume":"8","author":"Markowitz","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0795","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0800","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/03331024870070S6195","article-title":"Dihydroergotamine nasal spray in prevention and treatment of migraine attacks: two controlled trials versus placebo","volume":"7","author":"Massiou","year":"1987","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0805","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1468-1331.2005.01076.x","article-title":"Efficacy of oral naratriptan in the treatment of menstrually related migraine","volume":"12","author":"Massiou","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0810","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archneur.1992.00530360073020","article-title":"Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. US Sumatriptan Research Group","volume":"49","author":"Mathew","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0815","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/WNL.49.6.1485","article-title":"Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group","volume":"49","author":"Mathew","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0820","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1526-4610.2003.03188.x","article-title":"Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review","volume":"43","author":"Mathew","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0825","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1526-4610.2003.03044.x","article-title":"Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg","volume":"43","author":"Mathew","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0830","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1526-4610.2006.00686.x","article-title":"Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)","volume":"47","author":"Mathew","year":"2007","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0835","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1526-4610.2009.01458.x","article-title":"Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life","volume":"49","author":"Mathew","year":"2009","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0840","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.2003.01081.x","article-title":"Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial","volume":"253","author":"Melchart","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0845","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10072-017-3119-y","article-title":"Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis","volume":"39","author":"Menshawy","year":"2018","journal-title":"Neurol Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0850","first-page":"17","article-title":"The first comparative double-blind trial on efficacy and safety of ergotamine based five-component combination and sumatriptan in migraine without aura","volume":"22","author":"Miljkovic","year":"2018","journal-title":"Hippokratia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0855","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10194-007-0386-7","article-title":"Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial","volume":"8","author":"Misra","year":"2007","journal-title":"J Headache Pain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0860","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/papr.12230","article-title":"The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double-blinded clinical trial","volume":"15","author":"Moshtaghion","year":"2015","journal-title":"Pain Pract"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0865","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0149-2918(96)80219-0","article-title":"Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System","volume":"18","author":"Mushet","year":"1996","journal-title":"Clin Ther"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0870","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1526-4610.1998.3803201.x","article-title":"Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study","volume":"38","author":"Myllyl\u00e4","year":"1998","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0875","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00868340","article-title":"Oral sumatriptan compared with placebo in the acute treatment of migraine","volume":"241","author":"Nappi","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0880","first-page":"835","article-title":"Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine","volume":"102","author":"Nett","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0885","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1526-4610.2001.111006248.x","article-title":"Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study","volume":"41","author":"Newman","year":"2001","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0890","unstructured":"No authors listed (1995). A randomised, double-blind, cross-over study to compare the efficacy and safety of sumatriptan 25 mg suppository with Cafergot suppository (2 mg ergotamine tartrate, 100 mg caffeine) (one suppository plus option of one additional suppository) in the acute treatment of migraine. [Online]. Available: www.gsk-clinicalstudyregister.com\/ [Accessed 06\/20\/2020."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0895","unstructured":"No authors listed (1996). SUMB2003; A double-blind, randomised, placebo-controlled study to compare the efficacy and safety of oral sumatriptan (25mg, 50mg and 100mg) in the acute treatment of migraine in adolescents. [Online]. Available: https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=SUMB2003 [Accessed 12\/18\/2020."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0900","unstructured":"No authors listed (2000). SUM30009; A single centre, placebo-controlled, double blind, randomised cross-over, single attack study evaluating the efficacy and tolerability of sumatriptan nasal spray 10mg for the acute treatment of migraine in children suffering from refractory migraine with\/without aura. [Online]. Available: https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=SUM30009 [Accessed 12\/18\/2020."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0905","unstructured":"No authors listed (2003). SUM30042; A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Cross-Over Study to Investigate the Efficacy, Safety and Tolerability of Sumatriptan Nasal Spray (10mg or 20mg) in the Treatment of Acute Migraine in Patients Aged 12-17. [Online]. Available: https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=SUM30042 [Accessed 12\/18\/2020."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0910","unstructured":"No authors listed (2007). Maxalt and Maxalt-MLT (rizatriptan tablets and rizatriptan orally disintegrating tablets) FDA Label [Online]. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/020864s013lbl.pdf [Accessed 04\/07\/2021."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0915","unstructured":"No authors listed (2012). Zomig (zolmitriptan) tablets and Zomig-ZMT (zomitriptan orally disintegrating tablets) FDA Label [Online]. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020768s019s021,021231s010s011lbl.pdf [Accessed 04\/07\/2021."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0920","unstructured":"No authors listed (2015). Onzetra Xsail (sumatriptan nasal powder) [Online]. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/206099s000lbl.pdf [Accessed 04\/06\/2021."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0925","unstructured":"No authors listed (2019). Migranal\u00ae Nasal Spray (FDA label) [Online]. Available: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020148Orig1s025lbl.pdf [Accessed 03\/24\/2021."},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0930","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1468-1331.2004.00914.x","article-title":"No effect of eletriptan administration during the aura phase of migraine","volume":"11","author":"Olesen","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0935","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00000441-196102000-00006","article-title":"A study of migraine pharmacotherapy","volume":"241","author":"Ostfeld","year":"1961","journal-title":"Am J Med Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0940","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/03331024850050S349","article-title":"A double blind trial with dihidroergotamine spray in migraine crisis","volume":"5","author":"Paiva","year":"1985","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0945","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1468-2982.2000.00091.x","article-title":"Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study","volume":"20","author":"Pascual","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0950","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1468-2982.2000.00069.x","article-title":"Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group","volume":"20","author":"Pascual","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0955","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/BF01642909","article-title":"Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study. Oral Sumatriptan Dose-defining Study Group","volume":"238","author":"Patten","year":"1991","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0960","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1468-1331.1999.610043.x","article-title":"Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine","volume":"6","author":"Peikert","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0965","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1526-4610.1998.3803184.x","article-title":"Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan","volume":"38","author":"Pfaffenrath","year":"1998","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0970","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/030006059502300202","article-title":"High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group","volume":"23","author":"Pini","year":"1995","journal-title":"J Int Med Res"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0975","first-page":"57","article-title":"Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group","volume":"19","author":"Pini","year":"1999","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0980","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1985.0502107.x","article-title":"Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound","volume":"5","author":"Pradalier","year":"1985","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0985","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/head.12767","article-title":"A randomized trial of ketorolac vs. sumatripan vs. placebo nasal spray (kspn) for acute migraine","volume":"56","author":"Rao","year":"2016","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0990","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.49.5.1210","article-title":"Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group","volume":"49","author":"Rapoport","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb0995","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1046\/j.1526-4610.42.s2.5.x","article-title":"Dose range-finding studies with frovatriptan in the acute treatment of migraine","volume":"42","author":"Rapoport","year":"2002","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1000","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.36.7.995","article-title":"Repetitive intravenous dihydroergotamine as therapy for intractable migraine","volume":"36","author":"Raskin","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1005","series-title":"Headache","author":"Raskin","year":"1988"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1010","first-page":"S15","article-title":"Oral sumatriptan for the long-term treatment of migraine: clinical findings","volume":"45","author":"Rederich","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1015","article-title":"Drugs for the acute treatment of migraine in children and adolescents","volume":"4","author":"Richer","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1526-4610.2010.01771.x","article-title":"Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database","volume":"51","author":"Rodgers","year":"2011","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/03331024850050S350","article-title":"Dihydroergotamine nasal spray for the treatment of migraine attacks: a comparative double-blind crossover study with placebo","volume":"5","author":"Rohr","year":"1985","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1030","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/S0022-510X(97)85361-0","article-title":"Efficacy and safety of naratriptan tablets in adolescent migraine","volume":"150","author":"Rothner","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1526-4610.2006.00313.x","article-title":"Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents","volume":"46","author":"Rothner","year":"2006","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1468-2982.1994.1404291.x","article-title":"A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice","volume":"14","author":"Russell","year":"1994","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1526-4610.1970.hed0904212.x","article-title":"Double-blind clinical evaluation of the efficacy and safety of ergostine-caffeine, ergotamine-caffeine, and placebo in migraine headache","volume":"9","author":"Ryan","year":"1970","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1050","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/WNL.49.5.1225","article-title":"Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies","volume":"49","author":"Ryan","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1055","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1046\/j.1526-4610.42.s2.6.x","article-title":"Clinical efficacy of frovatriptan: placebo-controlled studies","volume":"42","author":"Ryan","year":"2002","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1526-4610.1992.hed3201018.x","article-title":"Abortive headache therapy with intramuscular dihydroergotamine","volume":"32","author":"Saadah","year":"1992","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1065","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.410240607","article-title":"Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches","volume":"24","author":"Saito","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1468-2982.2002.00377.x","article-title":"Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study","volume":"22","author":"Sakai","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1185\/030079903125002973","article-title":"Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials","volume":"20","author":"Sakai","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1080","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P04.233","article-title":"The safety of triptan use for migraines in the elderly (P04.233)","volume":"78","author":"Salem","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00919706","article-title":"Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group","volume":"241","author":"Salonen","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00541538","article-title":"Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing","volume":"30","author":"Sanders","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1095","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/WNL.59.8.1210","article-title":"Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study","volume":"59","author":"Sandrini","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-2982.2004.00723.x","article-title":"LY293558, a novel AMPA\/GluR5 antagonist, is efficacious and well-tolerated in acute migraine","volume":"24","author":"Sang","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1105","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1468-2982.1997.1708867.x","article-title":"Improvement in migraine-specific quality of life in a clinical trial of rizatriptan","volume":"17","author":"Santanello","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1110","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1111\/j.1526-4610.2006.00601.x","article-title":"Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine","volume":"46","author":"Saper","year":"2006","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1115","first-page":"S10","article-title":"Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study","volume":"45","author":"Sargent","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1120","first-page":"7","article-title":"A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group","volume":"105","author":"Savani","year":"1999","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1526-4610.1995.hed3505256.x","article-title":"Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine","volume":"35","author":"Scherl","year":"1995","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1468-2982.2008.01654.x","article-title":"Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia","volume":"28","author":"Schoenen","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1526-4610.2003.03130.x","article-title":"Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs","volume":"43","author":"Schulman","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4065\/75.8.782","article-title":"Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"75","author":"Schulman","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/qjmed\/89.8.613","article-title":"Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice","volume":"89","author":"Scott","year":"1996","journal-title":"Qjm"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1150","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/0333102410390399","article-title":"Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders","volume":"31","author":"Seeburger","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1526-4610.2011.02027.x","article-title":"Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis","volume":"52","author":"Seeburger","year":"2012","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1526-4610.2002.02210.x","article-title":"Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine","volume":"42","author":"Sharma","year":"2002","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1526-4610.2003.03043.x","article-title":"Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States","volume":"43","author":"Sheftell","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clinthera.2005.04.003","article-title":"Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating\/rapid-release formulation of sumatriptan tablets","volume":"27","author":"Sheftell","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1175","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/head.13476","article-title":"STOP 101: A phase 1, randomized, open-label, comparative bioavailability study of inp104, dihydroergotamine mesylate (dhe) administered intranasally by a i123 precision olfactory delivery (pod((r)) ) device, in healthy adult subjects","volume":"59","author":"Shrewsbury","year":"2019","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1526-4610.2003.03034.x","article-title":"Ergotamine and dihydroergotamine: history, pharmacology, and efficacy","volume":"43","author":"Silberstein","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1185","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1526-4610.1990.hed3006334.x","article-title":"Repetitive intravenous DHE in the treatment of refractory headache","volume":"30","author":"Silberstein","year":"1990","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/01.WNL.0000134620.30129.D6","article-title":"A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine","volume":"63","author":"Silberstein","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1526-4610.2006.00633.x","article-title":"Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/01.wnl.0000316800.22949.20","article-title":"Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine","volume":"71","author":"Silberstein","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1205","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1526-4610.2009.01509.x","article-title":"Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation","volume":"49","author":"Silberstein","year":"2009","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0333102413508242","article-title":"Sumatriptan\/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study","volume":"34","author":"Silberstein","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/head.13700","article-title":"Dihydroergotamine (DHE)\u2014then and now: a narrative review","volume":"60","author":"Silberstein","year":"2020","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1220","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1526-4610.2005.05178.x","article-title":"Sumatriptan and naproxen sodium for the acute treatment of migraine","volume":"45","author":"Smith","year":"2005","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb9000","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/head.14184","article-title":"STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD\u00ae) of dihydroergotamine mesylate, over 24\/52 weeks in acute treatment of migraine attacks in adult patients","volume":"61","author":"Smith","year":"2021","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1225","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.49.5.1219","article-title":"Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group","volume":"49","author":"Solomon","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1230","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/0333102417724152","article-title":"Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study","volume":"38","author":"Spielmann","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1235","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2165\/00023210-200418150-00007","article-title":"Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet","volume":"18","author":"Spierings","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0333102417737765","article-title":"Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine","volume":"38","author":"Spierings","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1245","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1526-4610.2000.00082.x","article-title":"Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan","volume":"40","author":"Stark","year":"2000","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-2982.2002.00300.x","article-title":"Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks","volume":"22","author":"Stark","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1255","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1468-2982.2003.00617.x","article-title":"Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine","volume":"23","author":"Steiner","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1260","first-page":"135","article-title":"Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks","volume":"57","author":"Stepien","year":"2004","journal-title":"Wiad Lek"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1265","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1526-4610.2003.03162.x","article-title":"Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study","volume":"43","author":"Stronks","year":"2003","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1526-4610.1998.3804281.x","article-title":"Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group","volume":"38","author":"Teall","year":"1998","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1742-1241.1998.tb11555.x","article-title":"Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group","volume":"52","author":"Tepper","year":"1998","journal-title":"Int J Clin Pract"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1526-4610.2006.00300.x","article-title":"Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study","volume":"46","author":"Tepper","year":"2006","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1285","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1468-2982.2008.01578.x","article-title":"History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward","volume":"28","author":"Tfelt-Hansen","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1290","series-title":"Triptans, 5-HT1B\/1D Receptor Agonists in the Acute Treatment of Migraine","author":"Tfelt-Hansen","year":"2006"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1295","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(95)91554-0","article-title":"The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine","volume":"346","author":"Tfelt-Hansen","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1300","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1526-4610.1998.3810748.x","article-title":"Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group","volume":"38","author":"Tfelt-Hansen","year":"1998","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: a review and European consensus","volume":"123","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10194-006-0333-z","article-title":"Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study","volume":"7","author":"Tfelt-Hansen","year":"2006","journal-title":"J Headache Pain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1468-2982.1999.019004232.x","article-title":"Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo","volume":"19","author":"The Diclofenac-K\/Sumatriptan Migraine Study Group","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1320","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000116761","article-title":"A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine","volume":"31","author":"The Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1325","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000116759","article-title":"A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine","volume":"31","author":"The Multinational Oral Sumatriptan and Cafergot Comparative Study Group","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000116818","article-title":"A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine","volume":"32","author":"The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group","year":"1992","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1335","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000116632","article-title":"Sumatriptan\u2014an oral dose-defining study","volume":"31","author":"The Oral Sumatriptan Dose-Defining Study Group","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1340","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000116758","article-title":"Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine","volume":"31","author":"The Oral Sumatriptan International Multiple-Dose Study Group","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1345","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM199108013250504","article-title":"Treatment of migraine attacks with sumatriptan","volume":"325","author":"The Subcutaneous Sumatriptan International Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1350","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000116760","article-title":"Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device","volume":"31","author":"The Sumatriptan Auto-Injector Study Group","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1355","first-page":"171","article-title":"Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial","volume":"106","author":"Thomson","year":"1993","journal-title":"N Z Med J"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0333102413508661","article-title":"Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis","volume":"34","author":"Thorlund","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1365","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0333102416660552","article-title":"Comparative tolerability of treatments for acute migraine: a network meta-analysis","volume":"37","author":"Thorlund","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1370","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1526-4610.2005.05143_1.x","article-title":"The combination of naratriptan and prochlorperazine in migraine treatment","volume":"45","author":"Tietjen","year":"2005","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1375","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/WNL.47.2.361","article-title":"A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine","volume":"47","author":"Touchon","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1380","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1526-4610.1992.hed3206280.x","article-title":"Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks","volume":"32","author":"Treves","year":"1992","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1385","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1526-4610.1998.3808614.x","article-title":"Dihydroergotamine nasal spray in the treatment of acute migraine","volume":"38","author":"Treves","year":"1998","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1390","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/00023210-200620120-00005","article-title":"Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine","volume":"20","author":"Tuchman","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1395","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00023210-200822100-00007","article-title":"Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study","volume":"22","author":"Tuchman","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1400","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0333102413515342","article-title":"Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study","volume":"34","author":"Tullo","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1405","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1468-2982.1987.0702131.x","article-title":"Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo","volume":"7","author":"Tulunay","year":"1987","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1410","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.52.7.1507","article-title":"Intranasal sumatriptan for the acute treatment of migraine in children","volume":"52","author":"Ueberall","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1415","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1468-2982.1992.1205308.x","article-title":"Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group","volume":"12","author":"Visser","year":"1992","journal-title":"Cephalalgia"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1420","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archneur.1996.00550110072014","article-title":"Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch\/US Rizatriptan Study Group","volume":"53","author":"Visser","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1425","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1526-4610.2004.04171.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies","volume":"44","author":"Visser","year":"2004","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1430","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1726-4901(09)70300-4","article-title":"Intranasal sumatriptan study with high placebo response in Taiwanese patients with migraine","volume":"70","author":"Wang","year":"2007","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1435","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.2.5705.325","article-title":"Controlled clinical trial of ergotamine tartrate","volume":"2","author":"Waters","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1440","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1526-4610.1994.hed3406371.x","article-title":"Home administration of intramuscular DHE for the treatment of acute migraine headache","volume":"34","author":"Weisz","year":"1994","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1445","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/00019053-200018060-00003","article-title":"Effectiveness of eletriptan in reducing time loss caused by migraine attacks","volume":"18","author":"Wells","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1450","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.clinthera.2006.03.013","article-title":"A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults","volume":"28","author":"Wendt","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1455","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1526-4610.1993.hed3309471.x","article-title":"Office-based treatment of acute migraine with dihydroergotamine mesylate","volume":"33","author":"Winner","year":"1993","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1460","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archneur.1996.00550020092020","article-title":"A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine","volume":"53","author":"Winner","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1465","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S0022-510X(97)85694-8","article-title":"Adolescent migraine: efficacy and safety of sumatriptan tablets","volume":"150","author":"Winner","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1470","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1542\/peds.106.5.989","article-title":"A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents","volume":"106","author":"Winner","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1475","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1526-4610.2002.02013.x","article-title":"Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study","volume":"42","author":"Winner","year":"2002","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1480","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4065\/78.10.1214","article-title":"Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies","volume":"78","author":"Winner","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1485","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1526-4610.2006.00339.x","article-title":"Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study","volume":"46","author":"Winner","year":"2006","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1490","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1526-4610.2007.00755.x","article-title":"Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial","volume":"47","author":"Winner","year":"2007","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1495","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/head.12555","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence","volume":"55","author":"Winner","year":"2015","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1500","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/head.12859","article-title":"Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ)","volume":"56","author":"Winner","year":"2016","journal-title":"Headache"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1505","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0317167100118943","article-title":"Canadian Headache Society Guideline: acute drug therapy for migraine headache","volume":"40","author":"Worthington","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1510","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s10194-016-0703-0","article-title":"Network meta-analysis of migraine disorder treatment by NSAIDs and triptans","volume":"17","author":"Xu","year":"2016","journal-title":"J Headache Pain"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1515","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-1241.1972.tb04381.x","article-title":"A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine","volume":"26","author":"Yuill","year":"1972","journal-title":"Br J Clin Pract"},{"key":"10.1016\/B978-0-12-823357-3.00008-2_bb1520","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.44.3_Part_1.447","article-title":"Dihydroergotamine nasal spray for the acute treatment of migraine","volume":"44","author":"Ziegler","year":"1994","journal-title":"Neurology"}],"container-title":["Handbook of Clinical Neurology","Migraine Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128233573000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128233573000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:16:11Z","timestamp":1753967771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128233573000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780128233573"],"references-count":304,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-823357-3.00008-2","relation":{},"ISSN":["0072-9752"],"issn-type":[{"value":"0072-9752","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}